{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:14:42Z","timestamp":1788250482219,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08493, 26K12030"],"award-info":[{"award-number":["23K08493, 26K12030"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11060-026-05731-z","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:24:56Z","timestamp":1785515096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of RANO resect group classification post-chemoradiotherapy in IDH-wildtype glioblastoma"],"prefix":"10.1007","volume":"179","author":[{"given":"Yuta","family":"Mitobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonehiro","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitada","family":"Hiraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kanoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7651-1374","authenticated-orcid":false,"given":"Yukihiko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"Supplement6","key":"5731_CR1","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","volume":"26","author":"M Price","year":"2024","unstructured":"Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA et al (2024) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017\u20132021. Neuro-Oncol 26(Supplement6):vi1\u201385. https:\/\/doi.org\/10.1093\/neuonc\/noae145 PubMed PMID: 39371035; PubMed Central PMCID: PMC11456825","journal-title":"Neuro-Oncol"},{"issue":"1","key":"5731_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2011.2","volume":"115","author":"N Sanai","year":"2011","unstructured":"Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3\u20138. https:\/\/doi.org\/10.3171\/2011.2.jns10998 PubMed PMID: 21417701","journal-title":"J Neurosurg"},{"issue":"11","key":"5731_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL et al (2016) Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. JAMA Oncol 2(11):1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373 PubMed PMID: 27310651; PubMed Central PMCID: PMC6438173","journal-title":"JAMA Oncol"},{"issue":"5","key":"5731_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3171\/2014.7","volume":"121","author":"MM Grabowski","year":"2014","unstructured":"Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH et al (2014) Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121(5):1115\u20131123. https:\/\/doi.org\/10.3171\/2014.7.JNS132449 PubMed PMID: 25192475","journal-title":"J Neurosurg"},{"issue":"5","key":"5731_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuonc\/noac193","volume":"25","author":"P Karschnia","year":"2023","unstructured":"Karschnia P, Young JS, Dono A, H\u00e4ni L, Sciortino T, Bruno F et al (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncol 25(5):940\u2013954. https:\/\/doi.org\/10.1093\/neuonc\/noac193 PubMed PMID: 35961053; PubMed Central PMCID: PMC10158281","journal-title":"Neuro-Oncol"},{"issue":"4","key":"5731_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3171\/2015.5.JNS142087","volume":"124","author":"YM Li","year":"2016","unstructured":"Li YM, Suki D, Hess K, Sawaya R (2016) The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124(4):977\u2013988. JNS142087 PubMed PMID: 26495941","journal-title":"J Neurosurg"},{"key":"5731_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jocn","volume":"72","author":"J Dimou","year":"2020","unstructured":"Dimou J, Beland B, Kelly J (2020) Supramaximal resection: A systematic review of its safety, efficacy and feasibility in glioblastoma. J Clin Neurosci Off J Neurosurg Soc Australas 72:328\u2013334. https:\/\/doi.org\/10.1016\/j.jocn2019.12.021 PubMed PMID: 31864830","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"issue":"1","key":"5731_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.10.JNS203366","volume":"136","author":"T Vivas-Buitrago","year":"2022","unstructured":"Vivas-Buitrago T, Domingo RA, Tripathi S, De Biase G, Brown D, Akinduro OO et al (2022) Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma. J Neurosurg 136(1):1\u20138 203366 PubMed PMID: 34087795; PubMed Central PMCID: PMC9248270","journal-title":"J Neurosurg"},{"issue":"1","key":"5731_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/jjco\/hyae130","volume":"55","author":"Y Sekino","year":"2025","unstructured":"Sekino Y, Sonoda Y, Shibahara I, Mizusawa J, Sasaki K, Sekita T et al (2025) Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO). Jpn J Clin Oncol 55(1):75\u201379. https:\/\/doi.org\/10.1093\/jjco\/hyae130 PubMed PMID: 39292165","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"5731_CR10","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/foc.2007.22","volume":"22","author":"W Stummer","year":"2007","unstructured":"Stummer W (2007) Mechanisms of tumor-related brain edema. Neurosurg Focus 22(5):E8. https:\/\/doi.org\/10.3171\/foc.2007.22.5.9 PubMed PMID: 17613239","journal-title":"Neurosurg Focus"},{"issue":"2","key":"5731_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-021-03762-2","volume":"153","author":"A Dasgupta","year":"2021","unstructured":"Dasgupta A, Geraghty B, Maralani PJ, Malik N, Sandhu M, Detsky J et al (2021) Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema. J Neurooncol 153(2):251\u2013261. https:\/\/doi.org\/10.1007\/s11060-021-03762-2 PubMed PMID: 33905055","journal-title":"J Neurooncol"},{"key":"5731_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.25259\/SNI_63_2024","volume":"15","author":"S Kamimura","year":"2024","unstructured":"Kamimura S, Mitobe Y, Nakamura K, Matsuda K, Kanemura Y, Kanoto M et al (2024) Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type. Surg Neurol Int 15:108 https:\/\/doi.org\/10.25259\/SNI_63_2024. PubMed PMID: 38628517; PubMed Central PMCID: PMC11021064","journal-title":"Surg Neurol Int"},{"issue":"1","key":"5731_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12880-025-01839-2","volume":"25","author":"B Shukir","year":"2025","unstructured":"Shukir B, Szivos L, Barzo P, Kis D (2025) Preoperative FLAIR images for identifying glioblastoma boundaries. BMC Med Imaging 25(1):302. https:\/\/doi.org\/10.1186\/s12880-025-01839-2 PubMed PMID: 40739201; PubMed Central PMCID: PMC12309083","journal-title":"BMC Med Imaging"},{"issue":"1","key":"5731_CR14","doi-asserted-by":"publisher","first-page":"vdad126","DOI":"10.1093\/noajnl\/vdad126","volume":"5","author":"LS Bjorland","year":"2023","unstructured":"Bjorland LS, Mahesparan R, Fluge \u00d8, Gilje B, D\u00e6hli Kurz K, Farbu E (2023) Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study. Neuro-Oncol Adv 5(1):vdad126. https:\/\/doi.org\/10.1093\/noajnl\/vdad126 PubMed PMID: 37868696; PubMed Central PMCID: PMC10590175","journal-title":"Neuro-Oncol Adv"},{"issue":"10","key":"5731_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996 https:\/\/doi.org\/10.1056\/NEJMoa043330. PubMed PMID: 15758009","journal-title":"N Engl J Med"},{"issue":"23","key":"5731_CR16","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B et al (2017) Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318(23):2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718 PubMed PMID: 29260225; PubMed Central PMCID: PMC5820703","journal-title":"JAMA"},{"issue":"10","key":"5731_CR17","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/j.1349-7006.2009.01270.x","volume":"100","author":"Y Sonoda","year":"2009","unstructured":"Sonoda Y, Kumabe T, Nakamura T, Saito R, Kanamori M, Yamashita Y et al (2009) Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci 100(10):1996\u20131998. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01270.x PubMed PMID: 19765000; PubMed Central PMCID: PMC11159618","journal-title":"Cancer Sci"},{"issue":"1","key":"5731_CR18","doi-asserted-by":"publisher","first-page":"vdaa114","DOI":"10.1093\/noajnl\/vdaa","volume":"2","author":"Z Kikuchi","year":"2020","unstructured":"Kikuchi Z, Shibahara I, Yamaki T, Yoshioka E, Shofuda T, Ohe R et al (2020) TERT promoter mutation associated with multifocal phenotype and poor prognosis in patients with IDH wild-type glioblastoma. Neuro-Oncol Adv 2(1):vdaa114. https:\/\/doi.org\/10.1093\/noajnl\/vdaa114 PubMed PMID: 33134923; PubMed Central PMCID: PMC7586143","journal-title":"Neuro-Oncol Adv"},{"issue":"1","key":"5731_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-019-0749-8","volume":"7","author":"T Umehara","year":"2019","unstructured":"Umehara T, Arita H, Yoshioka E, Shofuda T, Kanematsu D, Kinoshita M et al (2019) Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts. Acta Neuropathol Commun 7(1):99. https:\/\/doi.org\/10.1186\/s40478-019-0749-8 PubMed PMID: 31215469; PubMed Central PMCID: PMC6580599","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"5731_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software EZR for medical statistics. Bone Marrow Transpl 48(3):452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 PubMed PMID: 23208313; PubMed Central PMCID: PMC3590441","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"5731_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","volume":"6","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P et al (2020) Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol 6(4):495\u2013503. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6143 PubMed PMID: 32027343; PubMed Central PMCID: PMC7042822","journal-title":"JAMA Oncol"},{"issue":"15","key":"5731_CR22","doi-asserted-by":"publisher","first-page":"e70016","DOI":"10.1002\/cncr.70016","volume":"131","author":"LY Tang","year":"2025","unstructured":"Tang LY, Botros D, Kim AA, Khalafallah AM, Dux H, Fox K et al (2025) Impact of peri-tumoral resection on survival in primary glioblastoma. Cancer 131(15):e70016. https:\/\/doi.org\/10.1002\/cncr.70016 PubMed PMID: 40704606","journal-title":"Cancer"},{"key":"5731_CR23","doi-asserted-by":"publisher","unstructured":"Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 34(1):45\u201360; discussion 60\u201361. https:\/\/doi.org\/10.1097\/00006123-199401000-00008. PubMed PMID: 8121569","DOI":"10.1097\/00006123-199401000-00008"},{"issue":"7","key":"5731_CR24","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1007\/s00330-011-2081-y","volume":"21","author":"SMK Belhawi","year":"2011","unstructured":"Belhawi SMK, Hoefnagels FWA, Baaijen JC, Aliaga ES, Reijneveld JC, Heimans JJ et al (2011) Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. Eur Radiol 21(7):1526\u20131534. https:\/\/doi.org\/10.1007\/s00330-011-2081-y PubMed PMID: 21331595; PubMed Central PMCID: PMC3101346","journal-title":"Eur Radiol"},{"issue":"3","key":"5731_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18383\/j.tom.2017.00009","volume":"3","author":"MD Garrett","year":"2017","unstructured":"Garrett MD, Yanagihara TK, Yeh R, McKhann GM, Sisti MB, Bruce JN et al (2017) Monitoring Radiation Treatment Effects in Glioblastoma: FLAIR Volume as Significant Predictor of Survival. Tomography 3(3):131\u2013137. https:\/\/doi.org\/10.18383\/j.tom.2017.00009 PubMed PMID: 30042977; PubMed Central PMCID: PMC6024439","journal-title":"Tomography"},{"issue":"3","key":"5731_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1245\/s10434-016-5635-z","volume":"24","author":"R Grossman","year":"2017","unstructured":"Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ et al (2017) Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival. Ann Surg Oncol 24(3):794\u2013800. https:\/\/doi.org\/10.1245\/s10434-016-5635-z PubMed PMID: 27766560","journal-title":"Ann Surg Oncol"},{"key":"5731_CR27","doi-asserted-by":"publisher","unstructured":"Shimoda Y, Kanamori M, Yamashita S, Shibahara I, Umezawa R, Mugikura S, et al. Residual pattern of the hyperintense area on T2-weighted magnetic resonance imaging after initial treatment predicts the pattern and location of recurrence in patients with newly diagnosed glioblastoma. World Neurosurg. 2025;193:517\u201332. https:\/\/doi.org\/10.1016\/j.wneu.2024.10.012","DOI":"10.1016\/j.wneu.2024.10.012"},{"issue":"10","key":"5731_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003 https:\/\/doi.org\/10.1056\/NEJMoa043331. PubMed PMID: 15758010","journal-title":"N Engl J Med"},{"issue":"5","key":"5731_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3171\/jns.2002.96","volume":"96","author":"MJ McGirt","year":"2002","unstructured":"McGirt MJ, Villavicencio AT, Bulsara KR, Friedman HS, Friedman AH (2002) Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases. J Neurosurg 96(5):941\u2013945. https:\/\/doi.org\/10.3171\/jns.2002.96.5.0941 PubMed PMID: 12005403","journal-title":"J Neurosurg"},{"issue":"1","key":"5731_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11060-015","volume":"126","author":"S Ohue","year":"2016","unstructured":"Ohue S, Kohno S, Inoue A, Yamashita D, Suehiro S, Seno T et al (2016) Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence. J Neurooncol 126(1):119\u2013126. https:\/\/doi.org\/10.1007\/s11060-015-1941-8 PubMed PMID: 26384812","journal-title":"J Neurooncol"},{"issue":"1","key":"5731_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41598-022-27128-4","volume":"13","author":"O Haim","year":"2023","unstructured":"Haim O, Agur A, Efrat OT, Valdes P, Ram Z, Grossman R (2023) The clinical significance of radiological changes associated with gliadel implantation in patients with recurrent high grade glioma. Sci Rep 13(1):11. https:\/\/doi.org\/10.1038\/s41598-022-27128-4 PubMed PMID: 36593342; PubMed Central PMCID: PMC9807577","journal-title":"Sci Rep"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05731-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05731-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05731-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:27:21Z","timestamp":1788247641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05731-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5731"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05731-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted following the tenets stipulated in the Declaration of Helsinki and approved by the Yamagata University Institutional Review Board (approval number: 2025-042), which permitted the analysis and publication of all clinical variables under approved informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients included in the study provided informed consent for their participation.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23"}}